Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
The Ets transcription factor PU.1 is a hematopoietic master regulator essential for the development of myeloid and B-cell lineages. As we previously reported, PU.1 sometimes represses transcription on forming a complex with mSin3A-histone deacetyl transferase-MeCP2. Here, we show an interaction between PU.1 and DNA methyltransferases, DNA methyltransferase (Dnmt)3a and Dnmt3b (Dnmt3s). Glutathione-S-transferase pulldown assay revealed that PU.1 directly interacted with the ATRX domain of Dnmt3s through the ETS domain. Dnmt3s repressed the transcriptional activity of PU.1 on a reporter construct with trimerized PU.1-binding sites. The repression was recovered by addition of 5-aza-deoxycitidine, a DNA methyltransferase inhibitor, but not trichostatin A, a histone deacetylase inhibitor. Bisulfite sequence analysis revealed that several CpG sites in the promoter region neighboring the PU.1-binding sites were methylated when Dnmt3s were coexpressed with PU.1. We also showed that the CpG sites in the p16(INK4A) promoter were methylated by overexpression of PU.1 in NIH3T3 cells, accompanied by a downregulation of p16(INK4A) gene expression. These results suggest that PU.1 may downregulate its target genes through an epigenetic modification such as DNA methylation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“previous studies have shown that PU.1 can form a complex with DNMT3a and DNMT3b [46].”
From PU.1 target genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-to-osteoclast differentiation (2013) · cites this paper as [46]
Citations
Cites
1 retracted
Majumder, S., Ghoshal, K., Datta, J., Bai, S., Dong, X., Quan, N., Plass, C., & Jacob, S. T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111662200 · Cited by 52 · cited 1×
“There is growing evidence to suggest that Dnmt1 interacts with the methylated DNAbinding protein (MBD) family (Tatematsu et al., 2000) and that Dnmt3s mediate the binding of MBD family members such as MeCP2 to methylated CpG sites (Majumder et al., 2002).”
BackgroundRetractedJenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756 · cited 1×
“Histone deacetylase removes the acetyl groups from the amino-terminal of the histone tails, which triggers the assembly of a tightly packed chromatin inaccessible to the transcriptional machinery (Jenuwein and Allis, 2001).”
BackgroundMethylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646 · cited 1×
“The method of bisulfite treatment has been explained previously (Herman et al., 1996).”
MethodMethylation-Induced Repression— Belts, Braces, and Chromatin
Bird, A. P., & Wolffe, A. P. (1999) · Cell · doi:10.1016/s0092-8674(00)81532-9 · Cited by 1,827
Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases
Okano, M., Xie, S., & Li, E. (1998) · Nature Genetics · doi:10.1038/890 · Cited by 1,651 · cited 2×
“Recent observations convinced us that the two major epigenetic gene-silencing mechanisms, the acetylation of histones and the methylation of DNA, are linked to Oncogene each other (Okano et al., 1998).”
BackgroundDNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci
Rountree, M. R., Bachman, K. E., & Baylin, S. B. (2000) · Nature Genetics · doi:10.1038/77023 · Cited by 1,052 · cited 1×
“All of them have been shown to interact directly with the mSin3A–HDACs complex (Robertson et al., 2000; Rountree et al., 2000; Fuks et al., 2001; Datta et al., 2003).”
BackgroundThe macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954 · cited 1×
“PU.1 was identified as the gene encoding the protein that binds to a purine-rich sequence (PU box) in the promoter region of the mouse major histocompatibility complex (MHC) class II I-Ab gene (Klemsz et al., 1990).”
BackgroundRobertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. A., Jones, P. L., & Wolffe, A. P. (2000) · Nature Genetics · doi:10.1038/77124 · Cited by 942 · cited 2×
“All of them have been shown to interact directly with the mSin3A–HDACs complex (Robertson et al., 2000; Rountree et al., 2000; Fuks et al., 2001; Datta et al., 2003).”
BackgroundCloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells
Bestor, T., Laudano, A., Mattaliano, R., & Ingram, V. (1988) · Journal of Molecular Biology · doi:10.1016/0022-2836(88)90122-2 · Cited by 913 · cited 1×
“There are at least three different major catalytically active Dnmts, Dnmt1 (Bestor et al., 1988), Dnmt3a and Dnmt3b (Okano et al., 1998), which are involved in cellular DNA methylation.”
BackgroundDi Croce, L., Raker, V. A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Coco, F. L., Kouzarides, T., Nervi, C., et al. (2002) · Science · doi:10.1126/science.1065173 · Cited by 787 · cited 1×
“The report that a complex of the PML–RAR fusion protein and Dnmts contributes to hypermethylation of the RARb2 promoter to silence the gene expression is the first example of site-specific DNA methylation (Croce et al., 2002).”
Background
Cited by
Epigenetics and gene expression
Gibney, E. R., & Nolan, C. M. (2010) · Heredity · doi:10.1038/hdy.2010.54 · Cited by 1,109
“DNMT3a and DNMT3b are responsible for de novo DNA methylation, targeting unmethylated CpG dinucleotides (Newell-Price et al., 2000; Wang et al., 2005; Suzuki et al., 2006; Hervouet et al., 2009), as well as working with DNMT1 to ensure propagation of methylation patterns during DNA replication (Weber and Schübeler, 20…”
BackgroundStructure and Function of Mammalian DNA Methyltransferases
Jurkowska, R. Z., Jurkowski, T. P., & Jeltsch, A. (2011) · ChemBioChem · doi:10.1002/cbic.201000195 · Cited by 690
Genomic patterns of DNA methylation: targets and function of an epigenetic mark
Weber, M., & Schübeler, D. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.04.011 · Cited by 387
Identification of genetic elements that autonomously determine DNA methylation states
Lienert, F., Wirbelauer, C., Som, I., Dean, A., Mohn, F., & Schübeler, D. (2011) · Nature Genetics · doi:10.1038/ng.946 · Cited by 386
Sensitivity of transcription factors to DNA methylation
Héberlé, É., & Bardet, A. F. (2019) · Essays in Biochemistry · doi:10.1042/ebc20190033 · Cited by 347
Reprogramming cell fates: reconciling rarity with robustness
Huang, S. (2009) · BioEssays · doi:10.1002/bies.200800189 · Cited by 320
Cell cycle regulation by long non-coding RNAs
Kitagawa, M., Kitagawa, K., Kotake, Y., Niida, H., & Ohhata, T. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1423-0 · Cited by 278
Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma
Hervouet, E., Peixoto, P., Delage-Mourroux, R., Boyer-Guittaut, M., & Cartron, P.-F. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0450-y · Cited by 247
Rosenbauer, F., Owens, B. M., Yu, L., Tumang, J. R., Steidl, U., Kutok, J. L., Clayton, L. K., Wagner, K., Scheller, M., Iwasaki, H., et al. (2006) · Nature Genetics · doi:10.1038/ng1679 · Cited by 237
Self-citationFrom 1957 to Nowadays: A Brief History of Epigenetics
Peixoto, P., Cartron, P.-F., Serandour, A. A., & Hervouet, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207571 · Cited by 215
de la Rica, L., Rodríguez-Ubreva, J., García, M., Islam, A. B., Urquiza, J. M., Hernando, H., Christensen, J., Helin, K., Gómez-Vaquero, C., & Ballestar, E. (2013) · Genome Biology · doi:10.1186/gb-2013-14-9-r99 · Cited by 211
“1 can form a complex with DNMT3a and DNMT3b [ 46 ] .”
InfluentialCross-talk between Site-specific Transcription Factors and DNA Methylation States
Blattler, A., & Farnham, P. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r113.512517 · Cited by 203
“Recent studies by de la Rica et al. (36) have shown that TET2 can interact with SPI1 and that both factors bind promoters that loseDNAmethylation during osteoclastogenesis.”
BackgroundAllosteric control of mammalian DNA methyltransferases – a new regulatory paradigm
Jeltsch, A., & Jurkowska, R. Z. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw723 · Cited by 203
“1 (179), Myc (180) and RP58 (181) and remodeling factors hSNF2 (152) and SMARCA4 (150).”
Epigenetic silencing of tumor suppressor genes: Paradigms, puzzles, and potential
Kazanets, A., Shorstova, T., Hilmi, K., Marques, M., & Witcher, M. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.04.001 · Cited by 195
Real-time in vivo imaging of p16Ink4a reveals cross talk with p53
Yamakoshi, K., Takahashi, A., Hirota, F., Nakayama, R., Ishimaru, N., Kubo, Y., Mann, D. J., Ohmura, M., Hirao, A., Saya, H., et al. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200904105 · Cited by 172
“Bisulfite sequencing analysis Bisulfite sequencing analysis was performed as described previously (Suzuki et al., 2006).”
MethodSelf-citationShamay, M., Krithivas, A., Zhang, J., & Hayward, S. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604469103 · Cited by 165
Huang, S., & Ingber, D. E. (2007) · Breast Disease · doi:10.3233/bd-2007-26104 · Cited by 160
Epigenetic Regulation of Human Trophoblastic Cell Migration and Invasion
Rahnama, F., Shafiei, F., Gluckman, P. D., Mitchell, M. D., & Lobie, P. E. (2006) · Endocrinology · doi:10.1210/en.2006-0288 · Cited by 159
“We demonstrate herein that trophoblastic migration and First Published Online August 3, 2006 Abbreviations: AJ, Adherens junction; AZA, 5 -aza-2 -deoxycytidine; DNMTs, DNA methyltransferases; FITC, fluorescein isothiocyanate; SHP, small heterodimer protein; siRNA, small interfering.”
BackgroundInfluentialSETD2: an epigenetic modifier with tumor suppressor functionality
Li, J., Duns, G., Westers, H., Sijmons, R., van den Berg, A., & Kok, K. (2016) · Oncotarget · doi:10.18632/oncotarget.9368 · Cited by 162
Li, F., Papworth, M. A., Minczuk, M. A., Rohde, C., Zhang, Y., Ragozin, S., & Jeltsch, A. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl1035 · Cited by 155
Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2
Suzuki, M. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1207 · Cited by 141
Self-citationVelasco, G., Hubé, F., Rollin, J., Neuillet, D., Philippe, C., Bouzinba-Segard, H., Galvani, A., Viegas-Péquignot, E., & Francastel, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000473107 · Cited by 136
Gebhard, C., Benner, C., Ehrich, M., Schwarzfischer, L., Schilling, E., Klug, M., Dietmaier, W., Thiede, C., Holler, E., Andreesen, R., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3406 · Cited by 125
Jiang, M., Zhang, Y., Fei, J., Chang, X., Fan, W., Qian, X., Zhang, T., & Li, J. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.132 · Cited by 111
DNMT3B Functions: Novel Insights From Human Disease
Gagliardi, M., Strazzullo, M., & Matarazzo, M. R. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00140 · Cited by 124
“, 2013) also act as positive regulators of the DNMT3B recruitment, leading to silencing of their target genes (Brenner et al., 2005; Suzuki et al., 2006; de la Rica et al., 2013).”
BackgroundThe de novo DNA methyltransferase DNMT3A in development and cancer
Chen, B., & Chan, W. (2014) · Epigenetics · doi:10.4161/epi.28324 · Cited by 122
Transcription factors drive B cell development
Hagman, J., & Lukin, K. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.01.007 · Cited by 82
Borghese, B., Barbaux, S., Mondon, F., Santulli, P., Pierre, G., Vinci, G., Chapron, C., & Vaiman, D. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0160 · Cited by 97
Kim, C.-S., Kim, Y.-R., Naqvi, A., Kumar, S., Hoffman, T. A., Jung, S.-B., Kumar, A., Jeon, B.-H., McNamara, D. M., & Irani, K. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr250 · Cited by 96
“[36] Suzuki M, Yamada T, Kihara-Negishi F, Sakurai T, Hara E, Tenen DG, et al.”
BackgroundKamei, Y., Suganami, T., Ehara, T., Kanai, S., Hayashi, K., Yamamoto, Y., Miura, S., Ezaki, O., Okano, M., & Ogawa, Y. (2010) · Obesity · doi:10.1038/oby.2009.246 · Cited by 93
Figueroa, M. E., Wouters, B. J., Skrabanek, L., Glass, J., Li, Y., Erpelinck-Verschueren, C. A. J., Langerak, A. W., Löwenberg, B., Fazzari, M., Greally, J. M., et al. (2009) · Blood · doi:10.1182/blood-2008-08-172387 · Cited by 91
Loaeza‐Loaeza, J., Beltrán, A. S., & Hernández‐Sotelo, D. (2020) · Genes · doi:10.3390/genes11111336 · Cited by 102
“The direct interaction of DNMT3A and DNMT3B was found in the −548 to −2 nt from first p16 ATG and the DNA methylation was sensed in the −480 to 18 of its promoter region [93].”
BackgroundDNA Methylation in Cancer: A Gene Silencing Mechanism and the Clinical Potential of Its Biomarkers
Fukushige, S., & Horii, A. (2013) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.229.173 · Cited by 94
“Second, cis-acting factors such as transcription factor PU.1 (Suzuki et al. 2006) and estrogen receptor ERα (Metivier et al. 2008) or histone methyltransferases such as G9a (Feldman et al. 2006; Tachibana et al. 2008) and enhancer of zeste homolog 2 (EZH2) (Viré et al. 2006) recruit DNA methyltransferases to methylati…”
BackgroundDigging deep into “dirty” drugs – modulation of the methylation machinery
Pleyer, L., & Greil, R. (2015) · Drug Metabolism Reviews · doi:10.3109/03602532.2014.995379 · Cited by 84
“The latter methylates CgP-islands in promoter regions with PU.1 binding sites (e.g. of p16INK4A (Kihara-Negishi et al., 2001; Suzuki et al., 2006) (Figure 2A)).”
BackgroundMyelodysplastic syndromes: molecular pathogenesis and genomic changes
Nolte, F., & Hofmann, W.-K. (2008) · Annals of Hematology · doi:10.1007/s00277-008-0502-z · Cited by 91
Epigenetic gene regulation in stem cells and correlation to cancer
Mathews, L., Crea, F., & Farrar, W. L. (2009) · Differentiation · doi:10.1016/j.diff.2009.04.002 · Cited by 81
“For example, Suzuki et al. demonstrated that PU.1 forms complexes with Dnmt3a and 3b, thereby allowing the methylation of specific genes, such as p16 (a gene that is frequently silenced in human leukemias) (Suzuki et al., 2006).”
BackgroundDNA methyltransferases in hematological malignancies
Hoang, N.-M., & Rui, L. (2020) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2020.04.006 · Cited by 81
Epigenetic Signatures of Salivary Gland Inflammation in Sjögren's Syndrome
Cole, M. B., Quach, H., Quach, D. L., Baker, A., Taylor, K. E., Barcellos, L. F., & Criswell, L. A. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39792 · Cited by 81
“1 is a known factor involved in B cell and macrophage differentiation, binding to the enhancers of many lineage-specific genes (40), and it may directly recruit DNA methylation machinery to repress target genes (41).”
BackgroundSandoval, J. E., Huang, Y.-H., Muise, A., Goodell, M. A., & Reich, N. O. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006795 · Cited by 66
“Finally, DNMT3A directly and indirectly interacts with a large number of partner proteins; in many cases such interactions are known to directly influence the enzyme’s specificity, subcellular localization, and overall activity (26, 27, 36, 37).”
BackgroundDo, C., Xing, Z., Yu, Y. E., & Tycko, B. (2017) · Epigenomics · doi:10.2217/epi-2016-0138 · Cited by 66
Zhang, S., Zhao, S., Qi, Y., Li, B., Wang, H., Pan, Z., Xue, H., Jin, C., Qiu, W., Chen, Z., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.12.035 · Cited by 65
“Chromatin immunoprecipitation ChIP assays were performed using a ChIP kit from Merck Millipore (17-295) according to the manufacturer’s instructions.”
MethodMakita, N., Suzuki, M., Asami, S., Takahata, R., Kohzaki, D., Kobayashi, S., Hakamazuka, T., & Hozumi, N. (2008) · Gene · doi:10.1016/j.gene.2007.12.025 · Cited by 69
Self-citationDNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
Sato, H., Wheat, J. C., Steidl, U. G., & Ito, K. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00187 · Cited by 64
Enzymology of Mammalian DNA Methyltransferases
Jurkowska, R. Z., & Jeltsch, A. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-43624-1_5 · Cited by 68
Dekkers, K. F., Neele, A. E., Jukema, J. W., Heijmans, B. T., & de Winther, M. P. J. (2019) · Epigenetics & Chromatin · doi:10.1186/s13072-019-0279-4 · Cited by 61
Deciphering the genetic code of DNA methylation
Wang, M., Ngo, V., & Wang, W. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa424 · Cited by 64
“For example, SPI1 can mediate both de novo methylation (by interacting with DNMT3B) and demethylation (by interacting with TET2) in a site-specific manner [51,52].”
BackgroundDynamic Regulation of DNA Methylation During Mammalian Development
Guibert, S., Forné, T., & Weber, M. (2009) · Epigenomics · doi:10.2217/epi.09.5 · Cited by 63
Epigenetic control of hematopoiesis: the PU.1 chromatin connection
van Riel, B., & Rosenbauer, F. (2014) · Biological Chemistry · doi:10.1515/hsz-2014-0195 · Cited by 48
Teitell, M. A., & Mikkola, H. K. A. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000205155.26315.c7 · Cited by 52
“1 also can participate in a co-repressor complex with histone deacetylase (HDAC) activity and directly binds DNMTs 3a and 3b to direct DNA methylation (58,59).”
BackgroundSquillaro, T., Alessio, N., Cipollaro, M., Renieri, A., Giordano, A., & Galderisi, U. (2010) · The FASEB Journal · doi:10.1096/fj.09-143057 · Cited by 51
“(53) demonstrated that MBD2-MBD3 heterodimer complexes bind hemimethylated DNA and recruit DNMT1.”
BackgroundYu, Y., Mo, Y., Ebenezer, D., Bhattacharyya, S., Liu, H., Sundaravel, S., Giricz, O., Wontakal, S., Cartier, J., Caces, B., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.423756 · Cited by 43
“1 has been shown to recruit DNA methyltransferases to enable site-specificmethylation (25), and it is conceivable that the dissociation of PU.”
BackgroundSelf-citationEpigenetic regulation of hematopoiesis by DNA methylation
Gore, A. V., Athans, B., Iben, J., Johnson, K., RUSSANOVA, V. R., Castranova, D., Pham, V. N., Butler, M. G., Williams‐Simons, L., Nichols, J. T., et al. (2016) · eLife · doi:10.7554/elife.11813 · Cited by 45
“Class 3 de novo DNMTs are known to interact with a number of different transcription factors in vitro (Brenner et al., 2005; Fuks et al., 2001; Suzuki et al., 2006), and these interactions are thought to influence their genomic targeting specificity (Jurkowska et al., 2011).”
BackgroundPU.1 Suppresses Th2 Cytokine Expression via Silencing of GATA3 Transcription in Dendritic Cells
Yashiro, T., Kubo, M., Ogawa, H., Okumura, K., & Nishiyama, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137699 · Cited by 45
Megiorni, F., Camero, S., Ceccarelli, S., McDowell, H. P., Mannarino, O., Marampon, F., Pizer, B. L., Shukla, R., Pizzuti, A., Marchese, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12688 · Cited by 42
The methylation landscape and its role in domestication and gene regulation in the chicken
Höglund, A., Henriksen, R., Fogelholm, J., Churcher, A. M., Guerrero‐Bosagna, C., Barrio, Á. M., Johnsson, M., Jensen, P., & Wright, D. (2020) · Nature Ecology & Evolution · doi:10.1038/s41559-020-01310-1 · Cited by 44
Tumor suppressor CEBPA interacts with and inhibits DNMT3A activity
Chen, X., Zhou, W., Song, R., Liu, S., Wang, S., Chen, Y., Gao, C., He, C., Xiao, J., Zhang, L., et al. (2022) · Science Advances · doi:10.1126/sciadv.abl5220 · Cited by 44
Association of CNVs with methylation variation
Shi, X. M., Radhakrishnan, S., Wen, J., Chen, J. Y., Chen, J., Lam, B. A., Mills, R. E., Stranger, B. E., Lee, C., & Setlur, S. R. (2020) · npj Genomic Medicine · doi:10.1038/s41525-020-00145-w · Cited by 42
Changes in chromatin structure and methylation of the human interleukin‐1β gene during monopoiesis
Weßels, I., Fleischer, D., Rink, L., & Uciechowski, P. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03243.x · Cited by 36
Complex Gene Regulatory Networks – from Structure to Biological Observables: Cell Fate Determination
Huang, S., & Kauffman, S. A. (2009) · Springer eBooks · doi:10.1007/978-0-387-30440-3_79 · Cited by 43
Weidner, C. I., Walenda, T., Lin, Q., Wölfler, M. M., Denecke, B., Costa, I. G., Zenke, M., & Wagner, W. (2013) · Scientific Reports · doi:10.1038/srep03372 · Cited by 38
Mahajan, V. S., Mattoo, H., Sun, N., Viswanadham, V., Yuen, G. J., Allard‐Chamard, H., Ahmad, M., Murphy, S. J. H., Cariappa, A., Tuncay, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22458-9 · Cited by 38
Misregulation of the expression and activity of DNA methyltransferases in cancer
Mensah, I. K., Norvil, A. B., AlAbdi, L., McGovern, S. E., Petell, C. J., He, M., & Gowher, H. (2021) · NAR Cancer · doi:10.1093/narcan/zcab045 · Cited by 42
“1 DNMT3A/B Recruits DNMTs to silence TSGs in NIH3T3 cells (205)”
BackgroundCannon, M. E., Currin, K. W., Young, K. L., Perrin, H. J., Vadlamudi, S., Safi, A., Song, L., Wu, Y., Wabitsch, M., Laakso, M., et al. (2019) · G3 Genes Genomes Genetics · doi:10.1534/g3.119.400294 · Cited by 39
De Novo DNA Methyltransferase DNMT3b Interacts with NEDD8-modified Proteins
Shamay, M., Greenway, M., Liao, G., Ambinder, R. F., & Hayward, S. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.155721 · Cited by 35
Li, C., Guo, S., Zhang, M., Gao, J., & Guo, Y. (2015) · Poultry Science · doi:10.3382/ps/pev016 · Cited by 33
“can induce site-specific DNA methylation (Suzuki et al., 2006).”
Spi-C Has Opposing Effects to PU.1 on Gene Expression in Progenitor B Cells
Schweitzer, B. L., Huang, K. J., Kamath, M. B., Emelyanov, A. V., Birshtein, B. K., & DeKoter, R. P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2195 · Cited by 33
“These enhancers, termed HS3a, HS1,2, HS3b, and HS4, gain hypersensitivity at various stages of B cell development (7, 8).”
BackgroundPU.1 Activates Transcription of SHP-1 Gene in Hematopoietic Cells
Wlodarski, P., Zhang, Q., Liu, X., Kasprzycka, M., Marzec, M., & Wasik, M. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607526200 · Cited by 29
CITED2-mediated human hematopoietic stem cell maintenance is critical for acute myeloid leukemia
Korthuis, P. M., Berger, G., Bakker, B., Geugien, M., Jaques, J., de Haan, G., Schuringa, J. J., Vellenga, E., & Schepers, H. (2014) · Leukemia · doi:10.1038/leu.2014.259 · Cited by 33
Metallothionein-1 Isoforms and Vimentin Are Direct PU.1 Downstream Target Genes in Leukemia Cells
Imoto, A., Okada, M., Okazaki, T., Kitasato, H., Harigae, H., & Takahashi, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.095810 · Cited by 33
Epigenetic Alterations Induced by Bacterial Lipopolysaccharides
Chiariotti, L., Coretti, L., Pero, R., & Lembo, F. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-24738-0_5 · Cited by 30
“The gene regulatory region was defi ned as a poised structure able to guarantee an effi cient transcription upon LPS stimulation (Tsukada et al. 1994 ; Liang et al. 2006 ; Suzuki et al. 2006 ).”
BackgroundDynamic Methylation of an L1 Transduction Family during Reprogramming and Neurodifferentiation
Salvador‐Palomeque, C., Sanchez-Luque, F. J., Fortuna, P. R. J., Ewing, A. D., Wolvetang, E. J., Richardson, S. R., & Faulkner, G. J. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00499-18 · Cited by 28
Xu, W., Cheng, N., Huang, K., Lin, Y., Wang, C., Xu, Y., Zhu, L., Du, D., & Luo, Y. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.02.039 · Cited by 25
Logan, P. C., Mitchell, M. D., & Lobie, P. E. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00265 · Cited by 28
Modeling the Hematopoietic Landscape
Brown, G., & Ceredig, R. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00104 · Cited by 27
De novo methyltransferases: Potential players in diseases and new directions for targeted therapy
Ponne, S., Selvam, M., Ashok, C., Srijyothi, L., & Baluchamy, S. (2020) · Biochimie · doi:10.1016/j.biochi.2020.07.004 · Cited by 28
Targeting Epigenetic Mechanisms in Vascular Aging
Lin, Z., Ding, Q., Li, X., Feng, Y., He, H., Huang, C., & Zhu, Y. Z. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.806988 · Cited by 24
“For example, complex in CpG sites in the promoter of p16(INK4A, an aging marker) leads to downregulation of p16(INK4A) expression (18).”
BackgroundDNA methylation is a guardian of stem cell self-renewal and multipotency
Gereige, L.-M., & Mikkola, H. K. A. (2009) · Nature Genetics · doi:10.1038/ng1109-1164 · Cited by 20
Identification of annexin 1 as a PU.1 target gene in leukemia cells
Iseki, Y., Imoto, A., Okazaki, T., Harigae, H., & Takahashi, S. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.04.010 · Cited by 28
Jiang, Y., Wang, Y.-H., Zhang, H., Wang, Z.-Y., & Liu, Y. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1831259 · Cited by 17
“Hippocampus levels of the proteins DNMT3a, DNMT1, GADD45b, and BDNF protein expression were significantly decreased (P 0.05) in the P21 (lactating) ZD offspring, whereas MeCP2 was significantly increased (P 0.05).”
BackgroundInfluentialEnzymology of Mammalian DNA Methyltransferases
Jurkowska, R. Z., & Jeltsch, A. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-11454-0_4 · Cited by 21
Zhou, Y., Zhang, T., Zhang, Q., Jiang, Y., Xu, D., Zhang, M., Shen, W., & Pan, Q. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3385-1 · Cited by 17
“Furthermore, other studies have also elucidated that the target genes are driven by common mechanisms involving in catalytic functions of DNMT [28–31].”
BackgroundComplex Gene Regulatory Networks – from Structure to Biological Observables: Cell Fate Determination
Huang, S., & Kauffman, S. A. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1800-9_35 · Cited by 23
Luo, L., Chen, W., Yin, J. Q., & Xu, R. (2017) · Scientific Reports · doi:10.1038/srep40463 · Cited by 16
Hagemann, S., Kuck, D., Stresemann, C., Prinz, F., Brueckner, B., Mund, C., Mumberg, D., & Sommer, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036125 · Cited by 14
Harnessing targeted DNA methylation and demethylation using dCas9
Pflueger, C., Swain, T., & Lister, R. (2019) · Essays in Biochemistry · doi:10.1042/ebc20190029 · Cited by 18
PU.1 is a major transcriptional activator of the tumour suppressor geneLIMD1
Foxler, D. E., James, V. H., Shelton, S. J., Vallim, T. Q. D. A., Shaw, P. E., & Sharp, T. V. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.013 · Cited by 18
Xu, X., Gao, X., Zhao, X., Liao, Y., Wu, J., Li, Q., & Li, J. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000438623 · Cited by 13
Yamada, T., Shimizu, T., Suzuki, M., Kihara‐Negishi, F., Nanashima, N., Sakurai, T., Yang, F., Akita, M., Oikawa, T., & Tsuchida, S. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.11.005 · Cited by 12
Self-citationDNA Methylation Analysis in Human Cancer
O’Sullivan, E., & Goggins, M. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-287-2_7 · Cited by 13
The power and the promise of epigenetic drugs in oncology
Scandolara, T. B., Siqueira, I. V. M., Pinto, L. F. R., & Soares‐Lima, S. C. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2025.1622115 · Cited by 11
Structure of the DNMT3B ADD domain suggests the absence of a DNMT3A-like autoinhibitory mechanism
Boyko, K. M., Arkova, O. V., Nikolaeva, A. Y., Popov, V. O., Georgiev, P. G., & Bonchuk, A. N. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.06.036 · Cited by 12
Loaeza‐Loaeza, J., Cerecedo-Castillo, Á. J., Rodríguez-Ruiz, H. A., Castro‐Coronel, Y., Moral-Hernández, Ó. D., Targa, F. R., & Hernández‐Sotelo, D. (2022) · Scientific Reports · doi:10.1038/s41598-022-24186-6 · Cited by 12
Tecik, M., & Adan, A. (2024) · Current Treatment Options in Oncology · doi:10.1007/s11864-024-01202-7 · Cited by 11
“The interaction of DNMT3A and DNMT3B with PU.1 in murine hematopoietic progenitor cells resulted in methylation of p16 tumor suppressor gene [93].”
BackgroundAn Unbiased Predictive Model to Detect DNA Methylation Propensity of CpG Islands in the Human Genome
Yalcin, D., & Otu, H. H. (2020) · Current Bioinformatics · doi:10.2174/1574893615999200724145835 · Cited by 11
Noro, F., Marotta, A., Bonaccio, M., Costanzo, S., Santonastaso, F., Orlandi, S., Tirozzi, A., Parisi, R., Curtis, A. D., Persichillo, M., et al. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02716-8 · Cited by 9
“A CXXC domain and a plant homeodomain region have been described to be part of DNMT1 and DNMT3 protein structure, respectively [58, 59].”
BackgroundGiannopoulou, A.-I., Kanakoglou, D. S., Papavassiliou, A. G., & Piperi, C. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188801 · Cited by 9
Prindull, G. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.07.009 · Cited by 9
“Because epigenomic deregulation from chromatin-modifying enzymes and transcriptional instabilities during G1 interfere with regular G1/S decision-making in genomic reorientation programs of neoplasms, the possibility exists that developmentally silenced genes are activated for expression [243,249,251].”
BackgroundYang, S. ‐., Guo, C., Xu, M., Sun, J., & Hong, X. (2014) · Insect Molecular Biology · doi:10.1111/imb.12120 · Cited by 9
“Dnmt3, which has two forms (Dnmt3a and Dnmt3b) in mammals, has the capacity for de novo methylation, involving the recognition and transfer of methyl groups to unmethylated DNA (Okano et al., 1998; Lyko et al., 1999; Suzuki et al., 2006; Chédin, 2011).”
BackgroundMethylation of TGM-3 Promoter and Its Association with Oral Squamous Cell Carcinoma (OSCC)
Shojaeian, S., Moazeni‐Roodi, A., Allameh, A., Garajei, A., Kazemnejad, A., Kabir, K., & Zarnani, A. (2021) · Avicenna Journal of Medical Biotechnology · doi:10.18502/ajmb.v13i2.5523 · Cited by 8
Jiang, S. S., Huang, S.-F. K., Huang, M., Chen, Y.-T., Jhong, H.-J., Chang, I., Chen, Y., Chang, J.-W., Chen, W., Lee, W., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.03.007 · Cited by 9
Metadata
- Authors
- Suzuki, M., Yamada, T., Kihara-Negishi, F., Sakurai, T., Hara, E., Tenen, D. G., Hozumi, N., & Oikawa, T.
- Affiliations
- Sasaki Institute (JP)
- Tokushima University (JP)
- Harvard University (US)
- Tokyo University of Science (JP)
- Corresponding author
- Oikawa, T
- Venue
- Oncogene
- Published
- 2005-12-05
- Volume
- 25
- Issue
- 17
- Pages
- 2477-2488
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1984410404
- Cited by
- 132
- References
- 43
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 4 · 2023: 1 · 2022: 10 · 2021: 6 · 2020: 9 · 2019: 8 · 2018: 4 · 2017: 2 · 2016: 11 · 2015: 5 · 2014: 7 · 2013: 10 · 2012: 4
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Keywords
- PU.1, DNMT3A, DNMT3B, DNA methylation, transcriptional repression, ETS transcription factors, CpG methylation, p16INK4a, epigenetic regulation, hematopoietic transcription factors, decitabine
- MeSH terms
- Decitabine, DNA Methyltransferase 3A, DNA Methyltransferase 3B, Proto-Oncogene Protein Spi-1, Animals, Azacitidine, DNA (Cytosine-5-)-Methyltransferases, Histone Deacetylases, Hydroxamic Acids, Promoter Regions, Genetic, Proto-Oncogene Proteins, Transcription, Genetic, Trans-Activators, DNA Methylation, Cyclin-Dependent Kinase Inhibitor p16, NIH 3T3 Cells, Chromatin Immunoprecipitation, Immunoprecipitation, Mice, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.